BioMed Central is an independent publishing house committed
to providing immediate open access to peer-reviewed biomedical research
All original research articles published
by BioMed Central are made freely and permanently accessible
online immediately upon publication.
BioMed Central views open
access to research as essential in order to ensure the rapid and efficient
communication of research findings.
BioMed Central is committed to maintaining high standards
through full and stringent peer review
All research articles in BioMed Central's
journals receive rapid and thorough peer review. The detailed peer-review
policy of each journal is the responsibility of the journal editor(s)
concerned. Many journals operate traditional anonymous peer review. Others,
including the medical BMC-series
titles, operate 'open peer review', in which reviewers are asked to sign their
reviews. For these titles, the pre-publication history of each paper (including
submitted versions, reviewers' reports and authors' responses) is linked to from
the published article.
BioMed Central offers a wide variety of journals and
BioMed Central's portfolio of 161 journals includes general titles such as Journal
of Biology alongside specialist journals (e.g. BMC
Journal) that focus on particular disciplines . All the research
published by BioMed Central's journals is open access, but BioMed Central
also provides access to various additional products and services that
require a subscription. For example, certain BioMed Central journals such
as Genome Biology publish
commissioned review content available only to subscribers. Other subscription-only
products include Faculty of 1000, a literature evaluation service that
covers both biology and medicine.
BioMed Central also operates Open
Repository, a hosted digital repository solution for institutions.